Royal Bank Of Canada Rockwell Medical, Inc. Transaction History

Royal Bank Of Canada

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.45 - $1.92 $292 - $387	202 Added 696.55%	231 $0
Q1 2024 Nov 05, 2024	SELL	$1.23 - $1.86 $248 - $375	-202 Reduced 87.45%	29 $0
Q1 2024 May 15, 2024	SELL	$1.23 - $1.86 $105 - $159	-86 Reduced 74.78%	29 $0
Q4 2023 Feb 14, 2024	BUY	$1.58 - $2.44 $181 - $280	115 New	115 $0
Q2 2023 Aug 14, 2023	SELL	$1.8 - $5.46 $30 - $92	-17 Reduced 73.91%	6 $0
Q1 2023 May 15, 2023	BUY	$1.03 - $2.62 $6 - $15	6 Added 35.29%	23 $0
Q4 2022 Feb 14, 2023	BUY	$0.84 - $1.39 $13 - $22	16 Added 1600.0%	17 $0
Q3 2022 Nov 14, 2022	BUY	$1.2 - $2.11 $1 - $2	1 New	1 $0

9.46M

339K

43.3K

Ticker RMTI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 10,675,200
Market Cap $24M
Description
Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iro...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.